Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DLCL.BOthis companyDr. Lalchandani Labs Ltd.	₹6.47	93.8×	0.43×	1.46×	5.92×	658.4%	59.7%	-11.9%	1.5%	0.4%	-2.0%	-17.9%	0.15×	-3.04×	-28.75×	3.79×	0.0%	3	1.33	2	B-
BERLDRG.BOBeryl Drugs Limited	₹25.49	22.95×	0.99×	0.5×	4.91×	-329.6%	28.6%	4.8%	2.2%	4.3%	5.2%	-5.3%	0.25×	0.89×	2.71×	1.52×	0.0%	5	3.87	1	C-
COLINZ.BOColinz Laboratories Limited	₹70.00	21.81×	1.12×	1.83×	7.57×	-17.6%	25.6%	4.1%	8.4%	5.1%	1.8%	28.8%	0.04×	-19.97×	5.39×	3.93×	0.0%	4	7.16	5	S-
DECIPHER.BODecipher Labs Ltd.	₹5.60	-1.71×	0.26×	0.38×	-1.49×	-90.6%	95.4%	-27.8%	-21.9%	-14.9%	-15.4%	-44.0%	0.02×	0.07×	0×	5.22×	0.0%	3	—	2	C
GIANLIFE.BOGian Life Care Limited	₹4.27	-438.25×	0.85×	2.46×	16.61×	501.1%	81.9%	72.9%	-0.6%	-0.2%	-18.0%	1.6%	0.3×	-1.22×	8.79×	1.45×	0.0%	2	—	2	B-
GVBL.BOGenomic Valley Biotech Ltd	₹50.13	289.5×	2.23×	32.79×	200.37×	-77.9%	100.0%	60.4%	11.3%	0.8%	3.1%	-0.2%	0×	-0.1×	0×	8.41×	0.0%	3	—	1	C-
Peer median	—	21.81×	0.99×	1.83×	7.57×	-77.9%	81.9%	4.8%	2.2%	0.8%	1.8%	-0.2%	0.04×	-0.1×	2.71×	3.93×	0.0%	3	5.52	2	—